The Facts and Figures on [market_watch ticker=ESPR item=name value=”Esperion Therapeutics Inc.”] ([market_watch ticker=ESPR item=ticker value=”NASDAQ: ESPR”])
Rebecca Harrison -
Lets take a close look at () today to get a better sense of the company and its current status, as well as the opportunity it may offer for prospective investors. Today's focus will be a fundamental evaluation of the stock from top to bottom.
As such, let's start with...
How is [market_watch ticker=CYCC item=name value=”Cyclacel Pharmaceuticals Inc.”] ([market_watch ticker=CYCC item=ticker value=”NASDAQ: CYCC”]) Executing its Strategy?
Rebecca Harrison -
We are going to take a close look at () today to get a better sense of the company and its current status, as well as the opportunity it may offer for prospective investors. Today's focus will be a fundamental evaluation of the stock from top to bottom.
As...
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) Set To Exercise 1-For-10 Reverse Stock Split
Rebecca Harrison -
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) recently announced that it would be exercising a 1-for-10 reverse stock split, of all outstanding shares of the company’s common stock. Moreover, RNN would also exercise a corresponding proportional reduction in the number of authorized capital shares of the company, as well. The action is...
Jaguar Animal Health Inc (NASDAQ:JAGX) has announced the signing of a distribution agreement, with JP Equine Services. The agreement would cover two non-prescription products from the company and would be distributed in Japan. Neonorm Foal and Neonorm Calf, the products in question, are natural, clinically tested, non-drug products that...
Replicel Life Sciences (OTCQB: REPCF)
The stem cell revolution is finally here, and it’s transforming modern medicine. Investors are flocking to this small-cap company with treatments for hair restoration, skin rejuvenation, and tendon repair.
When we stumbled upon Replicel Life Sciences (OTCQB: REPCF and TSX.V:RP) it really caught our attention. ...
Geron Corporation (NASDAQ:GERN) To Announce 1Q2017 Financial Results And Hold Annual Shareholder Meeting On May 9, 2017
Brandon Manns -
Geron Corporation (NASDAQ:GERN) is due to hold its annual meeting of shareholders on May 9, 2017, at 4:00 pm, PDT. The company has invited all stockholders to attend the meeting, which would be held at its office location, at 149 Commonwealth Drive, Menlo Park, California. Added to this, shareholders...
Altimmune Inc (NASDAQ:ALT) is a company that focuses in the manufacture of vaccines. The business guru says it will expand its business presence in Gatihersburg and this is a major addition to the fast rising bio-technology industry in Montgomery County.
A close outlook
The company believes that the new 14,000 square foot...
Shares of (NASDAQ:) are currently up by more than from the open today and are trading at $. More than shares have exchanged hands compared to an average trading volume of . At the current pps, the market cap stands at $. The stock prices of...
Although a tremendous progress has been made, large full-thickness skin defects are still associated with mortality due to a low availability of donor skin areas.
Autologous cultured epidermal autografts (CEA) were first to be used as an epidermal substitute; however, their functional and esthetic results were unsatisfying due to graft...
Aducanumab, a clinical treatment drug, primed to treat those with early symptoms of Alzheimer’s, recently went into Phase 1B clinical studies trial. Recently, the firm responsible for the manufacturing of the clinical treatment drugs, Biogen Inc. (NASDAQ:BIIB) released the data obtained from the Phase 1B trial.
The data will be...